Susquehanna International Group
ANTH

Susquehanna International Group’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Susquehanna International Group’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-784,744
Closed -$1.17M – 10754
2017
Q4 		$1.29M Buy
+784,744
New +$1.35M ﹤0.01% 4721
2017
Q3 		– Sell
-26,428
Closed -$37.5K – 10131
2017
Q2 		$43K Buy
+26,428
New +$59.3K ﹤0.01% 8922
2017
Q1 		– Sell
-7,022
Closed -$36K – 10626
2016
Q4 		$36K Sell
7,022
-2,219
-24% -$38.4K ﹤0.01% 9358
2016
Q3 		$233K Sell
9,241
-4,820
-34% -$122K ﹤0.01% 7341
2016
Q2 		$348K Buy
14,061
+11,997
+581% +$339K ﹤0.01% 6722
2016
Q1 		$60K Sell
2,064
-9,192
-82% -$249K ﹤0.01% 8617
2015
Q4 		$418K Buy
11,256
+1,275
+13% +$56.3K ﹤0.01% 7110
2015
Q3 		$486K Sell
9,981
-14,951
-60% -$1.04M ﹤0.01% 7179
2015
Q2 		$1.72M Buy
24,932
+18,694
+300% +$865K ﹤0.01% 5047
2015
Q1 		$223K Buy
6,238
+3,372
+118% +$99.8K ﹤0.01% 8483
2014
Q4 		$36K Sell
2,866
-10,557
-79% -$153K ﹤0.01% 9429
2014
Q3 		$206K Buy
13,423
+9,702
+261% +$204K ﹤0.01% 8632
2014
Q2 		$101K Buy
3,721
+2,275
+157% +$56.2K ﹤0.01% 9424
2014
Q1 		$39K Buy
1,446
+33
+2% +$838 ﹤0.01% 8736
2013
Q4 		$35K Buy
+1,413
New +$36.4K ﹤0.01% 8855

Other funds holding ANTH

WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Susquehanna International Group's ANTH Position: Q1 2018 in Review

Susquehanna International Group sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q1 2018, closing a stake of 784,744 shares — an estimated $1.17M sold.

Susquehanna International Group first reported a position in ANTH in Q4 2013 and held it in 15 quarters. The position peaked at $1.72M in Q2 2015. 28 funds tracked by Wall St. Rank hold ANTH as of Q1 2018.

  • Susquehanna International Group reported no remaining Anthera Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Susquehanna International Group sold 784,744 Anthera Pharmaceuticals, Inc. shares in Q1 2018, an estimated $1.17M.
  • Susquehanna International Group first reported a position in Anthera Pharmaceuticals, Inc. in Q4 2013 and held it in 15 quarters.
  • Susquehanna International Group's Anthera Pharmaceuticals, Inc. position peaked at $1.72M in Q2 2015.
  • 28 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q1 2018.

Based on Susquehanna International Group's 13F filing for Q1 2018, filed 15 May 2018.